[1]宋开星,邓梅花,陈锦宏,等.阿托伐他汀对HIV/AIDS患者抗病毒治疗后血脂异常的作用[J].医学信息,2022,35(04):159-161.[doi:10.3969/j.issn.1006-1959.2022.04.042]
　SONG Kai-xing,DENG Mei-hua,CHEN Jin-hong,et al.Effect of Atorvastatin on Dyslipidemia in HIV/AIDS Patients After Antiviral Therapy[J].Medical Information,2022,35(04):159-161.[doi:10.3969/j.issn.1006-1959.2022.04.042]
点击复制

阿托伐他汀对HIV/AIDS患者抗病毒治疗后血脂异常的作用()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年04期
页码:
159-161
栏目:
药物与临床
出版日期:
2022-02-15

文章信息/Info

Title:
Effect of Atorvastatin on Dyslipidemia in HIV/AIDS Patients After Antiviral Therapy
文章编号:
1006-1959（2022）04-0159-03
作者:
宋开星; 邓梅花; 陈锦宏; 方 敏; 梁飞立
横县人民医院感染性疾病科，广西 横县 530300
Author(s):
SONG Kai-xing; DENG Mei-hua; CHEN Jin-hong; FANG Min; LIANG Fei-li
Department of Infectious Diseases,Hengxian County People’s Hospital,Hengxian 530300,Guangxi,China
关键词:
阿托伐他汀; 人类免疫缺陷病毒; 艾滋病; 血脂异常
Keywords:
Atorvastatin; Human immunodeficiency virus; Acquired immune deficiency syndrome; Dyslipidemia
分类号:
R512.91
DOI:
10.3969/j.issn.1006-1959.2022.04.042
文献标志码:
A
摘要:
目的 探讨阿托伐他汀对人类免疫缺陷病毒/艾滋病（HIV/AIDS）患者抗病毒治疗后血脂异常的作用。方法 选取2018年7月-2019年9月我院接受抗病毒治疗的HIV/AIDS合并血脂异常患者74例作为研究对象，按照随机数字表法分成对照组和观察组，每组37例。对照组给予健康宣教、饮食及运动干预，观察组在对照组基础上联合阿托伐他汀钙片治疗，比较两组血脂指标（TC、TG、HDL-C、LDL-C）及不良反应发生情况。结果 观察组治疗后TC、LDL-C、TG水平低于治疗前，且低于对照组，差异有统计学意义（P＜0.05）；观察组治疗后HDL-C水平与治疗前比较，差异无统计学意义（P＞0.05）；对照组治疗前后TC、TG、HDL-C、LDL-C水平比较，差异无统计学意义（P＞0.05）。两组不良反应发生率比较，差异无统计学意义（P＞0.05）。结论 阿托伐他汀钙可以改善HIV/AIDS合并血脂异常患者的血脂水平，且不良反应发生率较低，应用安全有效。
Abstract:
Objective To investigate the effect of atorvastatin on dyslipidemia in HIV / AIDS patients after antiviral therapy.Methods A total of 74 patients with HIV/AIDS complicated with dyslipidemia who received antiviral therapy in our hospital from July 2018 to September 2019 were selected as subjects. They were divided into control group and observation group according to random number table method, with 37 cases in each group. The control group was given health education, diet and exercise intervention, and the observation group was treated with atorvastatin calcium tablets on the basis of the control group. The blood lipid indexes (TC, TG, HDL-C, LDL-C) and adverse reactions were compared between the two groups.Results The levels of TC, LDL-C and TG in the observation group after treatment were lower than those before treatment, and lower than those in the control group, the difference was statistically significant (P<0.05);there was no significant difference in the level of HDL-C before and after treatment in the observation group (P>0.05); there was no significant difference in the levels of TC, TG, HDL-C and LDL-C before and after treatment in the control group (P>0.05); there was no significant difference in the incidence of adverse reactions between the two groups (P>0.05).Conclusion Atorvastatin calcium can improve the blood lipid level of HIV/AIDS patients with dyslipidemia, and the incidence of adverse reactions is low, which is safe and effective.

参考文献/References:

[1]余旻虹,赵艳伟,杨慧,等.306例艾滋病患者的血脂异常情况及相关因素分析[J].中华实验和临床病毒学杂志,2020,34(2):122-127.[2]Sinha A,Feinstein MJ.Coronary Artery Disease Manifestations in HIV: What, How, and Why[J].Can J Cardiol,2019,35(3):270-279. [3]Gebhardt A,Fichtenbaum CJ.Current pharmacotherapy for the treatment of dyslipidemia associated with HIV infection[J].Expert Opin Pharmacother,2019,20(14):1719-1729. [4]诸骏仁,高润霖,赵水平,等.中国成人血脂异常防治指南(2016年修订版)[J].中国循环杂志,2016,31(10):937-953.[5]孙丽琴,刘甲野,王辉,等.2018年深圳市初治HIV感染者血脂异常患病率及影响因素分析[J].传染病信息,2020,33(2):122-128.[6]Jain A,Kolvekar T,Nair DR.HIV infection and lipids[J].Curr Opin Cardiol,2018,33(4):429-435. [7]Bowman ER,Cameron CM,Richardson B,et al.Macrophage maturation from blood monocytes is altered in people with HIV, and is linked to serum lipid profiles and activation indices: A model for studying atherogenic mechanisms[J].PLoS Pathog,2020,16(10):e1008869. [8]Bourgi K,Wanjalla C,Koethe JR.Inflammation and Metabolic Complications in HIV[J].Curr HIV/AIDS Rep,2018,15(5):371-381. [9]Ruiz-Padilla AJ,Ruiz-Noa Y,Del Rocio Ibarra-Reynoso L,et al.FGF21 and its Relationship with Inflammatory and Metabolic Parameters in HIV Patients after Antiretroviral Treatment[J].Curr HIV Res,2020,18(5):308-314. [10]Sil S,Niu F,Chivero ET,et al.Role of Inflammasomes in HIV-1 and Drug Abuse Mediated Neuroinflammaging[J].Cells,2020,9(8):1857. [11]Chakrabarti LA,Lortholary O.IRIS: a paradoxical inflammatory reaction in patients treated simultaneously for tuberculosis and HIV[J].Med Sci (Paris),2015,31(1):53-59.[12]严冬梅,王宗正,蔡琳,等.TLE方案对初治男男性行为者的HIV/AIDS患者血脂及致动脉粥样硬化率的影响[J].中国艾滋病性病,2021,27(1):21-24.[13]何盛华,谭清,周仲辉,等.中青年男性人类免疫缺陷病毒感染者/艾滋病患者初始抗反转录病毒治疗前后血脂变化及影响因素分析[J].中国病毒病杂志,2019,9(6):449-453.[14]黄宛香,李繁,黄树庭.二线方案致艾滋病患者高脂血症应用阿托伐他汀钙片与普伐他汀钠片临床疗效对照[J].解放军预防医学杂志,2019,37(5):41-42.[15]Courlet P,Decosterd LA,Alves Saldanha S,et al.Influence of Drug-Drug Interactions on the Pharmacokinetics of Atorvastatin and Its Major Active Metabolite ortho-OH-Atorvastatin in Aging People Living with HIV[J].Clin Pharmacokinet,2020,59(8):1037-1048. [16]杨靖,金一.依折麦布联合阿托伐他汀治疗血脂异常的临床疗效分析[J].中国临床医生杂志,2020,48(6):663-664.[17]Zanetti HR,Goncalves A,Teixeira Paranhos Lopes L,et al.Effects of Exercise Training and Statin Use in People Living with Human Immunodeficiency Virus with Dyslipidemia[J].Med Sci Sports Exerc,2020,52(1):16-24. [18]陈柳林,黄树庭.含克力芝HAART方案引起高脂血症临床干预的研究[J].中国艾滋病性病,2015,21(1):5-7.[19]杨茜岚,冯美江,何慧薇,等.瑞舒伐他汀和阿托伐他汀联合规律运动在冠心病治疗中的应用研究[J].海南医学,2014(15):2199-2201,2202.

相似文献/References:

[1]何 丽.三种他汀类药物治疗老年动脉粥样硬化性急性脑梗死合并高血脂效果对比[J].医学信息,2022,35(11):150.[doi:10.3969/j.issn.1006-1959.2022.11.040]
　HE Li.Comparison of Three Statins in the Treatment of Elderly Patients with Atherosclerotic Acute Cerebral Infarction Combined with Hyperlipidemia[J].Medical Information,2022,35(04):150.[doi:10.3969/j.issn.1006-1959.2022.11.040]
[2]王 毅.阿托伐他汀联合曲美他嗪治疗冠心病的临床效果评价[J].医学信息,2018,31(13):139.[doi:10.3969/j.issn.1006-1959.2018.13.041]
　WANG Yi.Clinical Evaluation of Atto Vastatin Combined with Trimetazidine in the Treatment of Coronary Atherosclerotic Heart Disease[J].Medical Information,2018,31(04):139.[doi:10.3969/j.issn.1006-1959.2018.13.041]
[3]王润俊.阿托伐他汀改善蛛网膜下腔出血患者的预后分析[J].医学信息,2018,31(14):142.[doi:10.3969/j.issn.1006-1959.2018.14.043]
　WANG Run-jun.Analysis of Atorvastatin Improves Prognosis in Patients with Subarachnoid Hemorrhage[J].Medical Information,2018,31(04):142.[doi:10.3969/j.issn.1006-1959.2018.14.043]
[4]袁 敏,周袁成.阿托伐他汀联合抗血小板药治疗脑血栓患者的疗效及对 血小板参数的影响[J].医学信息,2018,31(16):123.[doi:10.3969/j.issn.1006-1959.2018.16.038]
　YUAN Min,ZHOU Yuan-cheng.Effect of Atorvastatin Combined with Antiplatelet Drugs on Patients with Cerebral Thrombosis and its Influence on Platelet Parameters[J].Medical Information,2018,31(04):123.[doi:10.3969/j.issn.1006-1959.2018.16.038]
[5]王 蕾,苏华斌,肖冠英,等.急性阑尾炎合并艾滋病患者临床病理特点及其对手术方式的影响[J].医学信息,2018,31(20):45.[doi:10.3969/j.issn.1006-1959.2018.20.014]
　WANG Lei,SU Hua-bin,XIAO Guan-ying,et al.Clinicopathological Features of Acute Appendicitis Complicated with AIDS and its Effect on Surgical Methods[J].Medical Information,2018,31(04):45.[doi:10.3969/j.issn.1006-1959.2018.20.014]
[6]徐润鸿.血府逐瘀汤联合阿托伐他汀钙治疗急性脑梗死的临床观察[J].医学信息,2019,32(05):165.[doi:10.3969/j.issn.1006-1959.2019.05.054]
　XU Run-hong.Clinical Observation on Treatment of Acute Cerebral Infarction with Xuefu Zhuyu Decoction Combined with Atorvastatin Calcium[J].Medical Information,2019,32(04):165.[doi:10.3969/j.issn.1006-1959.2019.05.054]
[7]沈有录,卢红涛,刘维军.阿托伐他汀和瑞舒伐他汀对高海拔地区PCI患者血脂、炎症因子和血管内皮功能的影响[J].医学信息,2019,32(06):67.[doi:10.3969/j.issn.1006-1959.2019.06.022]
　SHEN You-lu,LU Hong-tao,LIU Wei-jun.Effects of Atorvastatin and Rosuvastatin on Blood Lipids,Inflammatory Factors and Vascular Endothelial Function in Patients with High Altitude PCI[J].Medical Information,2019,32(04):67.[doi:10.3969/j.issn.1006-1959.2019.06.022]
[8]曹鸣菲,雷德财,宋晓玉,等.四川省肿瘤医院2005~2018年肿瘤住院患者HIV抗体筛查结果分析[J].医学信息,2019,32(07):82.[doi:10.3969/j.issn.1006-1959.2019.07.024]
　CAO Ming-fei,LEI De-cai,SONG Xiao-yu,et al.Analysis of HIV Antibody Screening Results of Tumor Inpatients in Sichuan Cancer Hospital from 2005 to 2018[J].Medical Information,2019,32(04):82.[doi:10.3969/j.issn.1006-1959.2019.07.024]
[9]陈志萍.阿托伐他汀联合低分子肝素治疗短暂性脑缺血临床疗效[J].医学信息,2019,32(09):153.[doi:10.3969/j.issn.1006-1959.2019.09.051]
　CHEN Zhi-ping.Clinical Efficacy of Atorvastatin Combined with Low Molecular Weight Heparin in the Treatment of Transient Cerebral Ischemia[J].Medical Information,2019,32(04):153.[doi:10.3969/j.issn.1006-1959.2019.09.051]
[10]高占群,李 霜,刘 杨.苯那普利联合阿托伐他汀治疗冠心病合并2型糖尿病 心功能不全的临床效果[J].医学信息,2019,32(17):135.[doi:10.3969/j.issn.1006-1959.2019.17.044]
　GAO Zhan-qun,LI Shuang,LIU Yang.Clinical Effect of Benazepril Combined with Atorvastatin in the Treatment of Coronary Heart Disease Complicated with Type 2 Diabetes with Cardiac Insufficiency[J].Medical Information,2019,32(04):135.[doi:10.3969/j.issn.1006-1959.2019.17.044]

更新日期/Last Update: 1900-01-01